13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001789778
Total reported value
$158.8M
$158.8M
10 檔
56.0%
In Q1 2026, Blue Water Life Science Advisors, LP's U.S. equity holdings reached a combined market value of $158.8M, distributed across 10 disclosed stock positions.
Blue Water Life Science Advisors, LP executed strategic sector rebalancing during Q1 2026, establishing 2 new positions while fully exiting 1 holdings and trimming 4 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | TXG | 10x Genomics Inc-class A | Stock-Other | 18.56% | -3.06% | — | |
| 2 | GH | Guardant Health Inc | Stock-Healthcare | 17.94% | -7.10% | -31.77% | |
| 3 | CDNA | Caredx Inc | Stock-Other | 13.02% | +8.34% | +83.33% | |
| 4 | ADPT | Adaptive Biotechnologies | Stock-Other | 11.24% | +2.41% | -42.77% | |
| 5 | TWST | Twist Bioscience CORP | Stock-Other | 10.52% | -10.52% | EXIT | |
| 6 | PSNL | Personalis Inc | Stock-Other | 8.56% | +5.59% | — | |
| 7 | NTRA | Natera Inc | Stock-Healthcare | 7.18% | -1.28% | -68.34% | |
| 8 | QTRX | Quanterix CORP | Stock-Other | 6.05% | +3.40% | +2.39% | |
| 9 | TEM | Tempus Ai Inc-cl A | Stock-Healthcare | 5.67% | -1.82% | +81.01% | |
| 10 | BLLN | Billiontoone Inc Cl A | Stock-Other | 1.27% | +4.02% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | CDNA | Caredx Inc | +7% | +83.33% | Add |
| 2 | TWST | Twist Bioscience CORP | +2.9% | -27.94% | Trim |
| 3 | TEM | Tempus Ai Inc-cl A | +2.5% | +81.01% | Add |
| 4 | PSNL | Personalis Inc | +0.2% | — | Unchanged |
| 5 | QTRX | Quanterix CORP | -2.3% | +2.39% | Add |
| 6 | GH | Guardant Health Inc | -4.8% | -31.77% | Trim |
| 7 | ADPT | Adaptive Biotechnologies | -6.8% | -42.77% | Trim |
| 8 | NTRA | Natera Inc | -13.2% | -68.34% | Trim |
| 9 | TXG | 10x Genomics Inc-class A | — | NEW | New buy |
| 10 | GRAL | Grail Inc | — | EXIT | Sold out |
| 11 | BLLN | Billiontoone Inc Cl A | — | NEW | New buy |
According to official SEC Form 13F filings, Blue Water Life Science Advisors, LP reported a total U.S. public equity portfolio value of $158.8M across 10 disclosed positions in Q1 2026.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including TXG, GH, CDNA) accounted for 56.0% of total reported equity market value during Q1 2026.
Top New Position Initiated
TXG
市值: $23.1M
Top Position Liquidated / Trimmed
GRAL
前期市值: $8.5M
During Q1 2026, Blue Water Life Science Advisors, LP's top holdings by market value included TXG (18.6%)、GH (17.9%)、CDNA (13.0%). The largest single position, TXG, represented 18.6% of total portfolio value.
In Q1 2026, Blue Water Life Science Advisors, LP made 10 total portfolio adjustments, initiating 2 new buys, adding to 3 positions, trimming 4 holdings, and fully liquidating 1 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.